Stockreport

Lisata Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

Lisata Therapeutics, Inc.  (LSTA) 
PDF Promising preliminary Phase 2b (ASCEND) pancreatic cancer data (Cohort A) reported with Cohort B data anticipated in the coming months Enrollment completed in Qilu’s Ph [Read more]